Archives
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Z-VAD-FMK: Unraveling Caspase-3-Driven IL-18 Signaling in...
2025-09-29
Discover how Z-VAD-FMK, a potent cell-permeable pan-caspase inhibitor, enables novel insights into caspase-3-dependent IL-18 signaling and apoptosis inhibition. This article uniquely explores the intersection of caspase regulation, tumor immunology, and advanced applications in cancer and neurodegenerative disease models.
-
Z-VAD-FMK: Unlocking Caspase Signaling for Advanced Cance...
2025-09-28
Explore how Z-VAD-FMK, a potent cell-permeable pan-caspase inhibitor, drives breakthroughs in apoptosis and ferroptosis pathway research. Discover its unique mechanistic depth, applications in resistant cancer models, and integration with emerging ferroptosis insights.
-
Z-VAD-FMK: Advancing Caspase Inhibition in Axonal Fusion ...
2025-09-27
Explore how Z-VAD-FMK, a cell-permeable pan-caspase inhibitor, redefines apoptosis research and unveils new strategies for axonal fusion and nerve repair. This in-depth analysis connects apoptosis inhibition, ferroptosis, and regenerative neuroscience for cutting-edge experimental design.
-
Z-VAD-FMK: Unraveling Caspase Inhibition and Apoptotic Pa...
2025-09-26
Explore the advanced role of Z-VAD-FMK, a potent cell-permeable pan-caspase inhibitor, in dissecting apoptosis and regulated cell death pathways. This article offers a unique, mechanistic perspective on apoptosis inhibition, with emphasis on translational applications in disease models.
-
Bufuralol Hydrochloride: Unraveling Beta-Adrenoceptor Sig...
2025-09-25
Explore the multifaceted role of Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist, in cardiovascular pharmacology research. This article uniquely examines its mechanistic insights, applications in advanced pharmacokinetic models, and implications for translational β-adrenergic modulation studies.
-
5-Methyl-CTP: Unlocking Advanced mRNA Stability for Next-...
2025-09-24
Explore how 5-Methyl-CTP, a methyl-modified cytidine triphosphate, is transforming mRNA synthesis with enhanced stability and translation efficiency. This article uniquely examines its mechanistic role in mRNA vaccine innovation and emerging delivery platforms for personalized medicine.
-
Dlin-MC3-DMA: Mechanistic Insights into Ionizable Liposom...
2025-09-23
-
In contrast to the beneficial
2025-03-03
In contrast to the beneficial treatment of skin-inflammation with PAH containing coal tar, epidemiology showed that environmental pollution, containing AHR-activating PAH, lead to more eczema [80]. Of note, other epidemiological data suggested that Th17 cell polarization may be enhanced air pollutio
-
br Discussion Here we focused on seven plant alkaloids
2025-03-03
Discussion Here, we focused on seven plant alkaloids extracted from yokukansan. These alkaloids individually inhibited 5-HT-mediated 5-HT3A and 5-HT3AB receptor currents weakly. Simultaneous administration of these alkaloids, however, inhibited the 5-HT3A and 5-HT3AB receptor currents strongly. T
-
br Occurrence of Inosine in RNA Inosine is
2025-03-03
Occurrence of Inosine in RNA Inosine is widespread among various types of RNAs including transfer RNA (tRNA), ribosomal RNA (rRNA), messenger RNA (mRNA), long noncoding RNA (lncRNA), and microRNA (miRNA). Within these RNAs, inosine can appear in different locations as well. Table 1 lists examples
-
br Materials and methods br Results
2025-03-03
Materials and methods Results Discussion Very few ARF inhibitors have been developed to study the key functions these small GTP-binding proteins play in pathophysiology. The natural compound Brefeldin A (BFA) has exhibited drastic effects in cells such as collapse of the Golgi because of it
-
The synthetic route to M
2025-03-03
The synthetic route to M100907 developed by Rice was utilized, however, the chiral resolution was carried out at an earlier stage to provide the possibility of introducing different substituents onto the piperidinyl group. The conditions for this resolution were different from previously reported.
-
NT157 The syntheses of a and b
2025-03-03
The syntheses of 27a and 27b are shown in Scheme 5. Substituted naphthalene 21c was brominated using N-bromosuccinimide (NBS) and 2,2′-azobis(2-methylpropionitrile) (AIBN) to yield 25, which was subjected to lactam cyclization to form 26a and 26b, respectively. Deprotections of each NT157 yielded th
-
In this paper we described synthesis biological evaluation a
2025-03-01
In this paper, we described synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives 4a–o as 15-lipoxygenase inhibitors. Results and discussion Conclusion We designed and synthesized a novel of thiourea derivatives containing phenylsulfonamide mo
-
Thus phosphorylation of p was used to measure
2025-03-01
Thus, phosphorylation of p38 was used to measure the intracellular potency of ASK1 inhibitors. In this assay, HEK293/AP-1luc Talarozole expressing human full-length ASK1 were incubated with compound for 18 h and then lysed and the level of phospho-p38 was quantified using the HTRF assay [33]. Re